An easy-to-dismiss symptom in your foot could be a sign of several more serious illnesses

They may be far away from your major organs, but your feet can hold major clues about your health — especially if you’re ...

Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and ...

Johnson & Johnson (NYSE: JNJ) today announced new long-term 52-week data from the Phase 3 ICONIC-TOTAL studya evaluating icotrokinra, a first-in-class investigational targeted oral peptide that ...